Title: Design and synthesis of cannabinoid receptor 1 antagonists for peripheral selectivity.
Journal: Journal of medicinal chemistry 20120322
Title: Excretion, metabolism, and pharmacokinetics of 1-(8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl)-4-(ethylamino)piperidine-4-carboxamide, a selective cannabinoid receptor antagonist, in healthy male volunteers.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120301
Title: Anti-Obesity Drugs: A Review about Their Effects and Safety.
Journal: Diabetes & metabolism journal 20120201
Title: Excretion, metabolism, and pharmacokinetics of CP-945,598, a selective cannabinoid receptor antagonist, in rats, mice, and dogs.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20111201
Title: Efficacy and safety of CP-945,598, a selective cannabinoid CB1 receptor antagonist, on weight loss and maintenance.
Journal: Obesity (Silver Spring, Md.) 20110701
Title: Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
Journal: Journal of obesity 20110101
Title: In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB(1) receptor antagonist for the management of obesity.
Journal: Biochemical and biophysical research communications 20100402
Title: Chemical and biological investigation of cyclopropyl containing diaryl-pyrazole-3-carboxamides as novel and potent cannabinoid type 1 receptor antagonists.
Journal: Journal of medicinal chemistry 20090723
Title: Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis.
Journal: Expert opinion on emerging drugs 20090301
Title: Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist.
Journal: Journal of medicinal chemistry 20090122
Title: John R. Hadcock, et al. In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB1 receptor antagonist for the management of obesity. Biochemical and Biophysical Research Communications, 2010; 394;366-371.
Title: Griffith DA, et al. Discovery of 1-[9-(4-chlorophenyl) -8-(2-chlorophenyl)- 9H-purin-6-yl -4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist. JMedChem. 2009 ;5
